Zobrazeno 1 - 6
of 6
pro vyhledávání: '"O A, Lednev"'
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 12, Iss 1, Pp 79-89 (2022)
The available range of medicinal products is growing every year.The aim of the study was to analyse the range of medicines authorised in the Russian Federation.Materials and methods: the analysis covered the data presented in the State Register of Me
Externí odkaz:
https://doaj.org/article/8117ac3603e24d9fb558877a5bff2892
Autor:
O. A. Lednev
Publikováno v:
Медицинский совет, Vol 0, Iss 2, Pp 82-84 (2014)
High incidence of cardiovascular diseases globally, including arterial hypertension (AH) and coronary artery disease (CAD), as well as a considerable social impact made by the diseases and their complications, call for finding new ways to improve eff
Externí odkaz:
https://doaj.org/article/5fdcf86bfe04475bb09469ac5a0dc3d0
Publikováno v:
International Polymer Science and Technology. 32:55-62
Publikováno v:
Klinicheskaia meditsina. 88(2)
The aim of the work was to compare efficiency of traditional therapy with prestarium (tert-butylamine salt) and chronotherapy with prestarium A (arginine salt) in elderly patients with polymorbidity syndrome (diabetes mellitus, nephropathy, grade I-I
Publikováno v:
Klinicheskaia meditsina. 87(12)
We examined 20 patients (mean age 69.4 yr) with stage II AH and CHD. 13 ones suffered CHD with stable FC II and III angina, two others had myocardial infarction. The patients were given monopril, 10 mg BID (08.0020.00). Those with CHD were additional
Publikováno v:
Klinicheskaia meditsina. 87(10)
The study included 20 patients aged 61-86 (mean 73.1 +/- 3.1) years with stage II hypertensive disease, type 2 diabetes and nephropathy with signs of grade I chronic renal insufficiency (CRI). The major parameters measured were AP, HR, laboratory cha